13F-HR: Walgreens Boots Alliance Discloses Major Equity Holdings in Latest 13F Filing

Walgreens Boots Alliance's latest 13F filing reveals substantial holdings in BrightSpring Health Services and Cencora, Inc.

Summary

• Walgreens Boots Alliance, Inc. filed its Form 13F holdings report for the quarter ended March 31, 2025.
• The filing discloses holdings in two companies: BrightSpring Health Services Inc. and Cencora, Inc.
• The total value of the reported holdings is $3,089,905,728.
• The filing reports 11,239,996 shares of BrightSpring Health Services Inc. with a value of $203,331,528.
• The filing reports 10,380,000 shares of Cencora, Inc. with a value of $2,886,574,200.
• The report includes information for three other investment managers: Walgreen Co., WBA Investments, Inc., and Walgreens Boots Alliance Holdings LLC.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It provides factual information about the company's holdings.

Positives

• The filing provides transparency into Walgreens Boots Alliance's investment portfolio.
• The large holdings in Cencora, Inc. suggest a strong belief in the company's value.

Industry Context

13F filings are a standard requirement for institutional investment managers, providing insights into their investment strategies and portfolio composition. The holdings in BrightSpring Health Services and Cencora reflect Walgreens Boots Alliance's investment decisions within the healthcare and pharmaceutical distribution sectors.

Comparison to Industry Standards

• Comparing Walgreens Boots Alliance's holdings to those of other major pharmaceutical retailers and healthcare providers would provide a benchmark for assessing the company's investment strategy.
• For example, analyzing the 13F filings of CVS Health or UnitedHealth Group could reveal similarities or differences in their investment portfolios.
• Benchmarking against industry peers like McKesson Corporation (a competitor of Cencora) would offer insights into relative investment preferences within the pharmaceutical distribution space.

Stakeholder Impact

• Shareholders can use this information to understand Walgreens Boots Alliance's investment strategy.
• The disclosed holdings may influence investor perceptions of the company's financial health and strategic direction.

Key Dates

Keywords

13F filing, Walgreens Boots Alliance, BrightSpring Health Services, Cencora, equity holdings, investment portfolio